Literature DB >> 15206064

Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART.

Anne Drake1, Anne Mijch, Joe Sasadeusz.   

Abstract

Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection occurs commonly. The introduction of antiretroviral therapy can result in immune reconstitution hepatitis. We describe 2 coinfected patients who developed clinical flares of HBV disease, despite the inclusion of lamivudine, a drug with anti-HBV activity, in their HAART regimens. Potential strategies to manage individuals with HBV/HIV coinfection are discussed.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15206064     DOI： 10.1086/421386

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  18 in total

Review 1.  Management of the immune reconstitution inflammatory syndrome.

Authors:  Graeme Meintjes; James Scriven; Suzaan Marais
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

2.  A case for treating high hepatitis B DNA levels before starting HIV therapy.

Authors:  Jason V Baker; David R Boulware; Paul R Bohjanen
Journal:  AIDS       Date:  2006-11-28       Impact factor: 4.177

3.  Effect of hepatitis-B virus co-infection on CD4 cell count and liver function of HIV infected patients.

Authors:  H O Olawumi; D O Olanrewaju; A O Shittu; I A Durotoye; A A Akande; A Nyamngee
Journal:  Ghana Med J       Date:  2014-06

4.  Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living With HIV With Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial.

Authors:  McNeil Ngongondo; Sachiko Miyahara; Michael D Hughes; Xin Sun; Gregory P Bisson; Amita Gupta; Johnstone Kumwenda; Jeffrey A Lavenberg; Thiago Silva Torres; Mulinda Nyirenda; Katende Kenneth Kidonge; Mina C Hosseinipour
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

Review 5.  Immune restoration diseases reflect diverse immunopathological mechanisms.

Authors:  Patricia Price; David M Murdoch; Upasna Agarwal; Sharon R Lewin; Julian H Elliott; Martyn A French
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

6.  Hepatitis B Virus-HIV Coinfection: Forgotten but Not Gone.

Authors:  Narayan Dharel; Richard K Sterling
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-12

Review 7.  HIV/HBV coinfection in children and antiviral therapy.

Authors:  Sara A Healy; Sonia Gupta; Ann J Melvin
Journal:  Expert Rev Anti Infect Ther       Date:  2013-03       Impact factor: 5.091

8.  The prevalence of hepatitis B co-infection in a South African urban government HIV clinic.

Authors:  Cynthia Firnhaber; Anne Reyneke; Doreen Schulze; Babatyi Malope; Mhairi Maskew; Patrick MacPhail; Ian Sanne; Adrian Di Bisceglie
Journal:  S Afr Med J       Date:  2008-07

Review 9.  Evaluation and treatment of the patient coinfected with hepatitis B and HIV.

Authors:  Ellen Kitchell; Mamta K Jain
Journal:  Curr HIV/AIDS Rep       Date:  2008-08       Impact factor: 5.071

10.  Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa.

Authors:  Cynthia Firnhaber; Raquel Viana; Anne Reyneke; Doreen Schultze; Babatyi Malope; Mhairi Maskew; Adrian Di Bisceglie; Patrick MacPhail; Ian Sanne; Michael Kew
Journal:  Int J Infect Dis       Date:  2008-12-09       Impact factor: 3.623
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.